Publication:
Control of uterine hyperactivity caused by prostaglandin with intravenous terbutaline: A case report

dc.contributor.authorY. Herabutyaen_US
dc.contributor.authorP. O-Prasertsawaten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-10T08:56:42Z
dc.date.available2018-08-10T08:56:42Z
dc.date.issued1993-12-01en_US
dc.description.abstractProstaglandin E2 is beginning to be used more widely for the induction of labor in this country. The main concern with vaginal administration is the difficulty in stopping uterine hyperactivity. This report is a case where intravenous terbutaline was given as soon as hyperactivity and fetal heart rate deceleration were detected. Using this treatment, hyperactivity was controlled and the fetal heart rate returned to normal. Unfortunately/cesarean section was necessary for fetal distress which developed two and a half hours later when syntocinon® was started intravenously to augment the labor.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.76, No.SUPPL. 1 (1993), 100-104en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0027819311en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/22640
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027819311&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleControl of uterine hyperactivity caused by prostaglandin with intravenous terbutaline: A case reporten_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027819311&origin=inwarden_US

Files

Collections